Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-Rich Plasma Versus Saline Hydrodissection for Carpal Tunnel Syndrome
NCT07904650Phase 4Completed
- Sponsor
- Medical University of Lodz
- Start
- Mar 2025
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of platelet-rich plasma in carpal tunnel syndrome (CTS) (2 arms), sponsored by Medical University of Lodz. Primary endpoints: Boston Carpal Tunnel Questionnaire - Symptom Severity Scale at 6 months and Boston Carpal Tunnel Questionnaire - Functional Status Scale at 6 months. Started Mar 2025; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT07904650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07904650.